Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Bypass | 9 | 2013 | 101 | 1.530 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2013 | 73 | 0.780 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2011 | 25 | 0.690 |
Why?
|
| Myocardial Ischemia | 3 | 2011 | 106 | 0.650 |
Why?
|
| Aortic Valve | 3 | 2018 | 49 | 0.590 |
Why?
|
| Coronary Disease | 3 | 2007 | 213 | 0.530 |
Why?
|
| Bioprosthesis | 3 | 2018 | 58 | 0.450 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 39 | 0.440 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 42 | 0.400 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.390 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2018 | 25 | 0.390 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 28 | 0.390 |
Why?
|
| Propofol | 1 | 2011 | 19 | 0.390 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2010 | 12 | 0.350 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 45 | 0.350 |
Why?
|
| Preoperative Care | 2 | 2008 | 115 | 0.340 |
Why?
|
| Aortic Valve Stenosis | 2 | 2020 | 31 | 0.330 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 24 | 0.330 |
Why?
|
| Heart Diseases | 1 | 2010 | 116 | 0.320 |
Why?
|
| Postoperative Complications | 5 | 2013 | 785 | 0.320 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.310 |
Why?
|
| Premedication | 1 | 2008 | 13 | 0.310 |
Why?
|
| Treatment Outcome | 11 | 2018 | 3317 | 0.310 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 49 | 0.300 |
Why?
|
| Heart Valves | 2 | 2005 | 16 | 0.300 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 83 | 0.300 |
Why?
|
| Aged | 18 | 2020 | 10340 | 0.290 |
Why?
|
| Middle Aged | 18 | 2020 | 11868 | 0.290 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 27 | 0.290 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 401 | 0.280 |
Why?
|
| Male | 21 | 2020 | 19195 | 0.270 |
Why?
|
| Aprotinin | 1 | 2005 | 4 | 0.260 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2005 | 6 | 0.260 |
Why?
|
| Thymus Neoplasms | 1 | 2005 | 4 | 0.260 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2005 | 20 | 0.260 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2005 | 13 | 0.260 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 135 | 0.250 |
Why?
|
| Palliative Care | 1 | 2005 | 52 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 370 | 0.240 |
Why?
|
| Heart Valve Prosthesis | 2 | 2018 | 55 | 0.240 |
Why?
|
| Humans | 24 | 2020 | 32024 | 0.230 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2004 | 11 | 0.230 |
Why?
|
| Aneurysm, Dissecting | 1 | 2004 | 12 | 0.230 |
Why?
|
| Female | 18 | 2020 | 19953 | 0.230 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 6 | 0.230 |
Why?
|
| Enoxaparin | 1 | 2003 | 20 | 0.220 |
Why?
|
| Hemoglobins | 1 | 2003 | 49 | 0.220 |
Why?
|
| Blood Transfusion | 1 | 2003 | 74 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2018 | 3523 | 0.210 |
Why?
|
| Risk Factors | 8 | 2018 | 3869 | 0.210 |
Why?
|
| Prognosis | 4 | 2020 | 1505 | 0.200 |
Why?
|
| Time Factors | 5 | 2018 | 2152 | 0.180 |
Why?
|
| Struma Ovarii | 1 | 2019 | 1 | 0.180 |
Why?
|
| Teratoma | 1 | 2019 | 10 | 0.180 |
Why?
|
| Meiosis | 1 | 2019 | 33 | 0.170 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2011 | 57 | 0.170 |
Why?
|
| Adult | 9 | 2020 | 9366 | 0.170 |
Why?
|
| Genome, Human | 1 | 2019 | 132 | 0.170 |
Why?
|
| Echocardiography | 1 | 2020 | 158 | 0.160 |
Why?
|
| Carcinoma | 1 | 2019 | 92 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 94 | 0.160 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 45 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 160 | 0.160 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 243 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 29 | 0.150 |
Why?
|
| Femoral Artery | 1 | 2017 | 50 | 0.150 |
Why?
|
| Stents | 1 | 2018 | 178 | 0.150 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 90 | 0.140 |
Why?
|
| Survival Rate | 3 | 2010 | 885 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 4000 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 273 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2020 | 488 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2004 | 43 | 0.120 |
Why?
|
| Factor IX | 1 | 2013 | 11 | 0.110 |
Why?
|
| North Carolina | 2 | 2010 | 1516 | 0.110 |
Why?
|
| Cognition Disorders | 2 | 2007 | 384 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2010 | 1435 | 0.110 |
Why?
|
| Heparin | 2 | 2003 | 74 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2011 | 6 | 0.100 |
Why?
|
| Embolism, Cholesterol | 1 | 2011 | 6 | 0.090 |
Why?
|
| Probability | 3 | 2009 | 158 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 900 | 0.090 |
Why?
|
| Critical Care | 1 | 2011 | 107 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2009 | 195 | 0.090 |
Why?
|
| Swine | 2 | 2009 | 215 | 0.090 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2007 | 6 | 0.090 |
Why?
|
| Exercise Test | 1 | 2010 | 227 | 0.080 |
Why?
|
| Ranitidine | 1 | 2009 | 2 | 0.080 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2009 | 2 | 0.080 |
Why?
|
| Peptic Ulcer | 1 | 2009 | 4 | 0.080 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2009 | 8 | 0.080 |
Why?
|
| Bioreactors | 1 | 2009 | 60 | 0.080 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 1 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 231 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2011 | 897 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 12 | 0.080 |
Why?
|
| Cross Infection | 1 | 2009 | 55 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2008 | 27 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 594 | 0.080 |
Why?
|
| Blood Volume | 1 | 2008 | 8 | 0.080 |
Why?
|
| Platelet Transfusion | 1 | 2008 | 16 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2010 | 379 | 0.080 |
Why?
|
| Reoperation | 2 | 2011 | 227 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2009 | 189 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 35 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2009 | 687 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 765 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2008 | 2283 | 0.070 |
Why?
|
| Logistic Models | 2 | 2009 | 781 | 0.070 |
Why?
|
| Saphenous Vein | 1 | 2007 | 20 | 0.070 |
Why?
|
| Prevalence | 1 | 2010 | 981 | 0.070 |
Why?
|
| Incidence | 2 | 2009 | 1200 | 0.070 |
Why?
|
| Animals | 3 | 2009 | 7466 | 0.070 |
Why?
|
| Hematocrit | 1 | 2005 | 23 | 0.070 |
Why?
|
| Causality | 1 | 2005 | 38 | 0.070 |
Why?
|
| Thymectomy | 1 | 2005 | 1 | 0.070 |
Why?
|
| Age Factors | 2 | 2007 | 1194 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2005 | 79 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2005 | 82 | 0.060 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 12 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 95 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 286 | 0.060 |
Why?
|
| Cattle | 1 | 2004 | 103 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 3 | 0.060 |
Why?
|
| Pericardium | 1 | 2004 | 52 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 111 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 456 | 0.060 |
Why?
|
| Comorbidity | 1 | 2005 | 569 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 532 | 0.060 |
Why?
|
| Suture Techniques | 1 | 2004 | 61 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2280 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2007 | 923 | 0.060 |
Why?
|
| Pipecolic Acids | 1 | 2003 | 6 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 70 | 0.060 |
Why?
|
| Sepsis | 1 | 2005 | 158 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 31 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 99 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2003 | 56 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2009 | 656 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 170 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 594 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2018 | 155 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2003 | 123 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 411 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 629 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 409 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2013 | 1831 | 0.050 |
Why?
|
| Mandibular Neoplasms | 1 | 2019 | 7 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 58 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 29 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 66 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 18 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 161 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 33 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 638 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 97 | 0.040 |
Why?
|
| Punctures | 1 | 2017 | 33 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2018 | 200 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 1125 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 349 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2017 | 188 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 318 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 355 | 0.030 |
Why?
|
| Chest Tubes | 1 | 2013 | 5 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 5 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 13 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 16 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 247 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 92 | 0.020 |
Why?
|
| Anti-Ulcer Agents | 1 | 2009 | 3 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 13 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 91 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 92 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 131 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 149 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2008 | 14 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 247 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 673 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 207 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 233 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 96 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2009 | 110 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 24 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1061 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 1269 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 757 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 371 | 0.020 |
Why?
|
| Constriction | 1 | 2005 | 13 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 85 | 0.020 |
Why?
|
| Epinephrine | 1 | 2005 | 40 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 47 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2005 | 64 | 0.020 |
Why?
|
| Dobutamine | 1 | 2005 | 68 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2003 | 22 | 0.010 |
Why?
|
| Aorta | 1 | 2003 | 125 | 0.010 |
Why?
|
| Critical Illness | 1 | 2003 | 87 | 0.010 |
Why?
|
| Dopamine | 1 | 2005 | 232 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 496 | 0.010 |
Why?
|